ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: TH-PO622

Association of Isolated Diastolic Hypertension With Risk of Renal and Cardiovascular Outcomes in CKD: A Report From the Chronic Renal Insufficiency Cohort (CRIC) Study

Session Information

Category: Hypertension and CVD

  • 1502 Hypertension and CVD: Clinical‚ Outcomes‚ and Trials


  • Alsaleh, Saud Abdulelah, University Hospitals, Cleveland, Ohio, United States
  • Dobre, Mirela A., University Hospitals, Cleveland, Ohio, United States
  • Delozier, Sarah, University Hospitals, Cleveland, Ohio, United States
  • Rahman, Mahboob, University Hospitals, Cleveland, Ohio, United States
  • Pradhan, Nishigandha, University Hospitals, Cleveland, Ohio, United States

Isolated Diastolic Hypertension (IDH) has drawn increased interest after the new definition of hypertension proposed by the 2017 ACC/AHA guidelines. Our analysis examined the prevalence of IDH, and the association of IDH with adverse renal and CV outcomes in patients with CKD


Participants in the CRIC Study; a multicenter observational cohort of ethnically diverse patients with CKD aged 21-74 years. IDH was defined as Systolic BP≤ 130 and DBP >80. Outcomes were composite kidney events (50% decline in eGFR or onset of ESKD), composite CV events (MI, CHF, stroke, PAD) and all-cause mortality. Cox proportional hazards models adjusted for demographic and clinical covariates


The cohort included 5621 participants with a mean age of 59 years; 44% were females and 43%were Black. 51% had diabetes. IDH was present in 6.1% fof participants at baseline. After median follow up of 17 years, there was no statistically significant association between IDH and composite kidney outcome (Hazrd ration (HR) 1.17 95% CI 0.93-1.47, p 0.18)The findings were consistent in subgroups by age ≤60 years or >60 years (HR 1.14 95% CI 0.88-1.48, p=0.31and HR 1.55 95% CI 0.84-2.83, p 0.16 respectively) No association was found between presence of IDH and risk of composite CV events (HR 0.91 (95% CI 0.65-1.27, p=0.58) or all-cause mortality (HR 0.82, 95% CI 0.57-1.19, p 0.30)


The Prevalence of IDH in this cohort of participants with CKD patients is 6.1%, similar to that in non-CKD populations. IDH is not associated with risk of adverse kidney and CV events irrespective of age

Association between IDH and clinical outcomes, compared to participants with normal systolic and diastolic BP
Hazard Ratio (95% CI)
Composite of MI, Stroke, CHF, PAD
Isolated Diastolic hypertension.55 (.41, .73), p < .001*.91 (.65, 1.27), p = .576
Isolated Systolic hypertension1.71 (1.52, 1.93), p < .001*1.20 (1.03, 1.39), p = .022*
Systolic Diastolic hypertension1.46 (1.26, 1.69), p < .001*1.41 (1.17, 1.71), p < .001*
All-cause mortality
Isolated Diastolic hypertension.42 (.30,.58), p < .001*.82 (.57, 1.19), p = .304
Isolated Systolic hypertension1.58 (1.38, 1.80), p < .001*1.11 (.94, 1.30), p = .221
Systolic Diastolic hypertension1.23 (1.04, 1.45), p = .017*1.42 (1.16, 1.74), p < .001*